Antonia Vlachou
Adjunct Professor, Systems Biology of Cancer
22713000
School of Sciences
Adjunct Faculty
Qualification | Year | Awarding Institution | Department | Thesis title |
PhD | 1997 | Baylor College of Medicine, USA | Cell and Molecular Biology | Functional analysis of COUP-TF |
BS | 1991 | University of Athens | School of Biology |
Period of employment | Employer | Location | Position | |
From | To | |||
05/2003 | present | Biomedical Research Foundation, Academy of Athens | Athens, Greece | Research Scientist, Professor Level, co-Director Proteomics |
O7/2013 | 09/2015 | Plymouth University, UK | Plymouth, UK | Reader/Associate Professor |
01/2001 | 03/2003 | Eastern VA Medical School, USA | Norfolk, VA | Research Assistant Professor |
Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
2018 | Proteomics biomarkers for solid tumors: Current status and future prospects. | Belczacka I, Latosinska A, Metzger J, Marx D, Vlahou A, Mischak H, Frantzi M. | Mass Spectrom Rev | doi: 10.1002/mas.21572 | |
2018 | Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease | Lygirou, V., Latosinska, A., Makridakis, M., Mullen, W., Delles, C., Schanstra, J.P., Zoidakis, J., Pieske, B., Mischak, H., Vlahou, A. | J Transl Med | 16 | 104 |
2017 | Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention | Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A | Oncotarget | 8 | 69435 |
2017 | Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy. | Krochmal M, Kontostathi G, Magalhães P, Makridakis M, Klein J, Husi H, Leierer J, Mayer G, Bascands JL, Denis C, Zoidakis J, Zürbig P, Delles C, Schanstra JP, Mischak H, Vlahou A. | Sci Rep | 7 | 15160 |
2017 | Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis. | Krochmal M, Cisek K, Filip S, Markoska K, Orange C, Zoidakis J, Gakiopoulou C, Spasovski G, Mischak H, Delles C, Vlahou A, Jankowski J. | Sci Rep | 7 | 9091 |
2016 | Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings. | Latosinska A, Makridakis M, Frantzi M, Borràs DM, Janssen B, Mullen W, Zoidakis J, Merseburger AS, Jankowski V, Mischak H, Vlahou A. | Sci Rep | 6 | 25619 |
2016 | PeptiCKDdb-peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease. | Krochmal, M., Fernandes, M., Filip, S., Pontillo, C., Husi, H., Zoidakis, J., Mischak, H., Vlahou, A., and Jankowski, J | Database (Oxford) | pii: baw128. | |
2016 | Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study | Frantzi M, van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP. | Clin Cancer Res 22, | 22 | 4077 |
2016 | Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models. | Frantzi M, Klimou Z, Makridakis M, Zoidakis J, Latosinska A, Borràs DM, Janssen B, Giannopoulou I, Lygirou V, Lazaris AC, Anagnou NP, Mischak H, Roubelakis MG, Vlahou A. | Oncotarget 7, | 7 | 70750 |
2015 | Developing proteomic biomarkers for bladder cancer: towards clinical application. | Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A. | Nat Rev Urol. | 12(6) | 317 |
Date | Title | Funded by | Project Role* |
01/2018-12/2022 | . “Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease” (Caresyan) | Marie Curie Initial Training Network | Partner Leader |
01/2017-12/2021 | . Translational Research Network in Prostate Cancer (Transpot) | Marie Curie Initial Training Network | Partner Leader |
01/2012-12/2016 | Title of study: NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies (NEURINOX). | European Union-Framework Program 7. | Partner Leader |
9/2013-8/2017 | “Clinical and system –omics for the identification of the MOlecular DEterminants of established Chronic Kidney Disease | Marie Curie Initial Training Network | Coordinator |
9/2013-8/2016 | Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction. (TransBioBC) | FP7-HEALTH-2013-INNOVATION-2: | Coordinator |
02/2014-02/2018 | Systems Biology to Identify Molecular Targets for Vascular Disease Treatment. (SysVasc) (Group Leader) | FP7-HEALTH-2013-INNOVATION-1: | Partner Leader |
10/2012-9/2016 | Molecular Medicine for Bladder Cancer (BCMolMed | Marie Curie- European-Industrial Doctorate (EID). | Partner Leader |
05/2010-05/2014 | IMPROVEMENT OF TOOLS AND PORTABILITY OF MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS AS APPLIED TO CHRONIC KIDNEY DISEASE (PROTOCLIN). | Marie Curie Industry-Academia Partnerships and Pathways (IAPP): | Partner Leader |
3/2008-7/2012 | Title of study: “Novel –MS based strategies for the Discovery and Evaluation of Cancer Biomarkers in urine: Application to Bladder Cancer Diagnosis (DECanBio)” | European Union-Framework Program 7. | Partner Leader |
5/2008-9/2012 | Urine and Kidney Proteomics | European Union- COST (Cooperation in the Field of Scientific and Technical Research) Action. | Coordinator |
Period | Organization | Title of Position or Service | Key Activities |
2014-present | European Society of Urological Research (ESUR) | Board Member | Organization of Annual meetings, promotion of urological research, coordination with other urological and oncological basic science organizations (eg SBUR, EAU, SUO) |
2010-2017 | European Medicine Agency | External expert, biomarker qualification team | Provide expert advice on applications for qualification of biomarkers |
2018- | Scientific Reports | Member of Editorial Board | Manage submitted manuscripts |
2012-2016 | FP7 Eu Program PRIORITY | Member of the Scientific Advisory Board | Oversee activities |
2014- | PLOS One | Member of Editorial Board | Manage submitted manuscripts |
Date | Title | Awarded by: |
March 2018 | Invited Chair of session ‘Urothelial tumors: Immune regulation’ and presenter of state of the art lecture “Proteomics of bladder cancer: Possibilities and perspectives” Annual meeting of the European Association of Urology, Copenhagen, Denmark | European Association of Urology |
March 2017 | Invited Moderator in the Joint session of the EAU Section of Urological Pathology (ESUP) and the EAU Section of Urological Research (ESUR) entitled“Biomarkers and tumour heterogeneity: Friends or enemies for differential therapy?” Congress of the European Association of Urology, London, UK | European Association of Urology |
April 2017 | Invited talk: “iMODE-CKD: Proteomic Data Base of CKD for Biomarker and Molecular Target Discovery’ Workshop entitled: “Introduction into Web-Based Data Mining of Large Scale Renal Data Sets”. ISN World Congress of Nephrology (WCN) 2017, Mexico City, Mexico | International Association of Nephrology |
April 2017 | Invited Talk“Proteomics for CKD Biomarker and Drug Target Discovery”. Joint Session ‘Big Data for Better Outcomes’ in partnership with the American Society of Nephrology (ASN). ISN World Congress of Nephrology (WCN) Mexico City, Mexico | International Association of Nephrology |
March 2016 | Invited Chair and presenter of summary –outlook of poster session “Regulation of urothelium carcinogenesis and progression” Annual meeting of the European Association of Urology, Munich, Germany | European Association of Urology |
September 2015 | Invited talk: “Urine proteomics for biomarker and drug target discovery”. Urinomics conference, Caparica, Portugal | Proteomass society |
April 2014. | Invited Chair of session entitled: “Characterisation of bladder cancer” . Joint Meeting of the EAU Section of Urological Imaging (ESUI), the EAU Section of Uropathology (ESUP) and the EAU Section of Urological Research (ESUR). Meeting of European Association of Urology (EAU), Stockholm, SE, | European Association of Urology |
April 2014 | Invited Chair of poster session entitled: “Bladder cancer biomarkers in prediction of disease aggressiveness” Meeting of European Association of Urology (EAU), Stockholm, SE | European Association of Urology |
November 2013. | Invited talk: “Proteomic bladder cancer biomarkers: from discovery to implementation”. Society of Basic Urologic Research (SBUR) meeting, Nashville TN, USA | European Society of Urological Research-Society of Basic Urological Research (US) |
September 2013. | Invited Talk:’Urinary Proteomics Biomarkers”. Urinomics Meeting, Caparica, Portugal | Proteomass society |
September 2013 | “Proteomics biomarkers for bladder cancer: from discovery to implementation”. European Society of Urological Research (ESUR) Meeting, Dresden, Germany | European Society of Urological Research |
July 2011 | Invited talk: “Application of proteomics technologies in the investigation of bladder cancer biomarkers”. Kitasato Symposium of Disease proteomics (KSDP), Tokyo, Japan | Japanese Proteomics Association |
Date | Title | Key Activities: |
2014,2015, 2018 | French National Research Council, France | Reviewer of Grant Applications |
2018 | Integration of omics Approaches and Systems Biology for Clinical Applications Editors: Antonia Vlahou, Harald Mischak, Fulvio Magni, Jerome Zoidakis John Wiley & Sons, in press | Book Editor |
2014, 2018 | Cancer Research UK | Reviewer of Grant Applications |
2017, 2018 | Science Foundation Ireland | Reviewer of Grant Applications |
2017 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Health,USA Review Panel | Reviewer of Grant applications |
2013-2017 | Annual training courses and scientific meetings of the iMODE-CKD collaborative project (one meeting per year) | Main scientific organizer of the annual training courses and scientific meetings of the iMODE-CKD collaborative project (to which I served as Chair) |
2016 | Post Graduate Certificate in Higher Education (PGCAP): received certificate (September 2016) after successful completion of PGCAP courses (PGCAP 700, 760, 770): Plymouth University | Formal certification for teaching in Higher Education Settings in the UK |
2015 | Clinical Proteomics (second edition), Methods in Molecular Biology Series. Editors: Antonia Vlahou, Manousos Makridakis. Springer, 2015. (ISBN: 978-1-4939-1871-3 (Print) 978-1-4939-1872-0 | Book Editor |
2008 | Clinical Proteomics. Methods in Molecular Biology Series. Editor: Antonia Vlahou. Springer, 2008 (ISBN: 9781588298379 | Book Editor |
2008-2012 | Annual meetings of the COST Action: Urine and Kidney Proteomics (EuroKUP) (one meeting per year) | Main scientific organizer of the annual meetings of the COST Action EuroKUP (to which I served as Chair) |